StockWatch
·

BIOFIL CHEMICALS & PHARMACEUTICALS LTD.

BSE: 524396

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-2.104.0410.1816.32Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
-8.244.6717.5830.49Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue12.35+63.2%7.57+783.5%0.86-93.7%13.54+110.5%6.43-23.0%8.35-41.2%14.20+488.3%2.41
Other Income0.06-42.3%0.11+38.6%0.08+23.5%0.06-97.8%2.83+1096.5%0.24+929.1%0.02+43.7%0.02
Total Income12.41+61.7%7.67+721.1%0.93-93.1%13.60+46.8%9.26+7.9%8.59-39.6%14.22+485.3%2.43
EXPENSES
Expenditure12.28+70.4%7.21+770.3%0.83-93.9%13.49+107.5%6.50-22.0%8.33-40.5%14.00+484.2%2.40
Tax0.03-90.3%0.26+833.1%0.03-2.1%0.03-92.0%0.35+548.5%0.05-4.9%0.06+612.5%0.01
PROFIT
PBT0.13-71.4%0.47+339.4%0.11-4.5%0.11-96.0%2.76+988.5%0.25+14.3%0.22+572.7%0.03
Net Profit0.11-48.6%0.21+167.9%0.08-5.3%0.08-96.5%2.41+1107.9%0.20+21.0%0.17+587.5%0.02
KEY METRICS
OPM %1.14%-4.60pp5.74%-5.34pp11.08%+10.24pp0.84%+0.75pp0.09%-1.20pp1.29%+0.66pp0.63%+4.40pp-3.77%
NPM %0.88%-1.89pp2.77%-5.70pp8.47%+7.86pp0.61%-25.41pp26.02%+23.70pp2.32%+1.16pp1.16%+0.17pp0.99%
EPS0.07-46.2%0.13+160.0%0.05+0.0%0.05-96.6%1.48+1133.3%0.12+20.0%0.10+900.0%0.01

Corporate Events

Board MeetingBIOFILCHEM
2026
14Nov

Board Meeting

To consider and approve the Un-Audited Financial Results of …

BSE Filing ↗
Board MeetingBIOFILCHEM
2026
23Sep

Board Meeting

The 41st Annual General Meeting (AGM) of the Company is sche…

BSE Filing ↗
Board MeetingBIOFILCHEM
2026
11Aug

Board Meeting

To consider and approve the Un-Audited Financial Results of …

BSE Filing ↗
Board MeetingBIOFILCHEM
2026
30May

Board Meeting

To consider and approve the Audited Financial Results of the…

BSE Filing ↗
Board MeetingBIOFILCHEM
2024
13Aug

Board Meeting

Consider and approve Un-Audited Financial Results of the Com…

BSE Filing ↗
Board MeetingBIOFILCHEM
2024
30May

Board Meeting

Consider and Approve Audited Financial Results for the fourt…

BSE Filing ↗